Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis - PubMed (original) (raw)

doi: 10.1016/j.ccr.2004.08.030.

Timothy K Cooper, Cynthia A Zahnow, Michael Overholtzer, Zhiquan Zhao, Marc Ladanyi, Judith E Karp, Nalan Gokgoz, Jay S Wunder, Irene L Andrulis, Arnold J Levine, Joseph L Mankowski, Stephen B Baylin

Affiliations

• PMID: 15488761
• DOI: 10.1016/j.ccr.2004.08.030

Free article

Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis

Wenyong Chen et al. Cancer Cell. 2004 Oct.

Free article

Abstract

The gene hypermethylated in cancer 1 (HIC1) is epigenetically inactivated, but not mutated, in cancer. Here we show that cooperative loss of Hic1 with p53, but not INK4a, yields distinct tumor phenotypes in mice. Germline deletion of one allele of each gene on the opposite chromosome yields breast and ovarian carcinomas and metastatic osteosarcomas with epigenetic inactivation of the wild-type Hic1 allele. Germline deletion of the two genes on the same chromosome results in earlier appearance and increased prevalence and aggressiveness of osteosarcomas with genetic deletion of both wild-type genes. In human osteosarcomas, hypermethylation of HIC1 is frequent only in tumors with p53 mutations. Our results indicate the importance of genes altered only through epigenetic mechanisms in cancer progression in conjunction with genetically modified tumor suppressor genes.

PubMed Disclaimer

Similar articles

• [Chromosome arm 17p13.3: could HIC1 be the one ?].
  Chopin V, Leprince D. Chopin V, et al. Med Sci (Paris). 2006 Jan;22(1):54-61. doi: 10.1051/medsci/200622154. Med Sci (Paris). 2006. PMID: 16386221 Review. French.
• Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.
  Chen WY, Wang DH, Yen RC, Luo J, Gu W, Baylin SB. Chen WY, et al. Cell. 2005 Nov 4;123(3):437-48. doi: 10.1016/j.cell.2005.08.011. Cell. 2005. PMID: 16269335
• Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1.
  Britschgi C, Rizzi M, Grob TJ, Tschan MP, Hügli B, Reddy VA, Andres AC, Torbett BE, Tobler A, Fey MF. Britschgi C, et al. Oncogene. 2006 Mar 30;25(14):2030-9. doi: 10.1038/sj.onc.1209240. Oncogene. 2006. PMID: 16301995
• Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors.
  Chen WY, Zeng X, Carter MG, Morrell CN, Chiu Yen RW, Esteller M, Watkins DN, Herman JG, Mankowski JL, Baylin SB. Chen WY, et al. Nat Genet. 2003 Feb;33(2):197-202. doi: 10.1038/ng1077. Epub 2003 Jan 21. Nat Genet. 2003. PMID: 12539045
• Implication of HIC1 (Hypermethylated In Cancer 1) in the DNA damage response.
  Dehennaut V, Leprince D. Dehennaut V, et al. Bull Cancer. 2009 Nov;96(11):E66-72. doi: 10.1684/bdc.2009.0959. Bull Cancer. 2009. PMID: 19822477 Review.

Cited by

• Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity.
  Wu Y, Lin Z, Tang X, Tong Z, Ji Y, Xu Y, Zhou Z, Yang J, Li Z, Liu T. Wu Y, et al. Front Immunol. 2023 Jun 14;14:1182030. doi: 10.3389/fimmu.2023.1182030. eCollection 2023. Front Immunol. 2023. PMID: 37388742 Free PMC article.
• Knockdown of ZBTB11 impedes R-loop elimination and increases the sensitivity to cisplatin by inhibiting DDX1 transcription in bladder cancer.
  Chen L, Liu Z, Tang H, Zhou Z, Chen J, Ma Z, Deng M, Li X, Wu Y, Zheng L, Zhou L, Zheng X, Liu Z. Chen L, et al. Cell Prolif. 2022 Dec;55(12):e13325. doi: 10.1111/cpr.13325. Epub 2022 Aug 26. Cell Prolif. 2022. PMID: 36054300 Free PMC article.
• The antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperation.
  Meier R, Greve G, Zimmer D, Bresser H, Berberich B, Langova R, Stomper J, Rubarth A, Feuerbach L, Lipka DB, Hey J, Grüning B, Brors B, Duyster J, Plass C, Becker H, Lübbert M. Meier R, et al. Blood Cancer J. 2022 Aug 22;12(8):122. doi: 10.1038/s41408-022-00715-4. Blood Cancer J. 2022. PMID: 35995769 Free PMC article. Clinical Trial.
• Regulation of SIRT1 and Its Roles in Inflammation.
  Yang Y, Liu Y, Wang Y, Chao Y, Zhang J, Jia Y, Tie J, Hu D. Yang Y, et al. Front Immunol. 2022 Mar 11;13:831168. doi: 10.3389/fimmu.2022.831168. eCollection 2022. Front Immunol. 2022. PMID: 35359990 Free PMC article. Review.
• The Role of Mesenchymal Stem Cells in the Induction of Cancer-Stem Cell Phenotype.
  Jing Y, Liang W, Zhang L, Tang J, Huang Z. Jing Y, et al. Front Oncol. 2022 Feb 17;12:817971. doi: 10.3389/fonc.2022.817971. eCollection 2022. Front Oncol. 2022. PMID: 35251985 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal